Company Filing History:
Years Active: 2000
Title: Myriam Francotte: Innovator in Herpes Simplex Vaccine Development
Introduction
Myriam Francotte is a notable inventor based in Rixensart, Belgium. She has made significant contributions to the field of vaccine development, particularly in the area of herpes simplex virus (HSV) research. Her innovative work has the potential to impact public health positively.
Latest Patents
Myriam Francotte holds a patent for a herpes simplex vaccine that comprises HSV glycoprotein gD and 3 deacylated monophosphoryl lipid A. This novel formulation aims to enhance the immune response against HSV, providing a promising avenue for future vaccine development.
Career Highlights
Francotte is associated with SmithKline Beecham Biologicals, where she has been instrumental in advancing vaccine research. Her dedication to her work has led to the development of groundbreaking solutions in the fight against viral infections.
Collaborations
Throughout her career, Myriam has collaborated with esteemed colleagues such as Jean-Paul H. Prieels and Moncef Mohamed Slaoui. These partnerships have fostered a collaborative environment that encourages innovation and scientific advancement.
Conclusion
Myriam Francotte's contributions to vaccine development, particularly in the realm of herpes simplex, highlight her role as a leading inventor in the field. Her work continues to inspire future research and innovation in vaccine technology.
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.